Read the Full Text
The full text of this article is available as PDF. Version of record published in Vol. 13 No. 3 (2021).
4,690 Views 1,591 Downloads
The outbreak of the COVID-19 virus has attacked all countries in the world and become a serious concern, also in Indonesia. Indonesia is trying to fight the spread of the COVID-19 disease with various forms of regulations issued, including the Government, Central Government, and District/City Governments. This policy was carried out to anticipate and prevent the spread of the COVID-19 virus outbreak. The study aims to look at the policies that the Bogor City Government has implemented and empirically test the data on COVID-19 patients to determine the factors that can influence the death of COVID-19 patients. The results showed that almost all COVID-19 patients adhere to the health protocol set by the Bogor City Government, but COVID-19 patients who are elderly, male, and have comorbid disease have a high risk of dying.
Korelasi Faktor Penyebab Kematian Pasien COVID-19 dan Penegakan Regulasi Penanganan COVID-19 di Kota Bogor
Merebaknya virus COVID-19 telah menyerang seluruh negara di dunia dan menjadi perhatian serius, juga di Indonesia. Indonesia berupaya memerangi penyebaran penyakit COVID-19 dengan berbagai bentuk regulasi yang dikeluarkan, antara lain Pemerintah, Pemerintah Pusat, dan Pemerintah Kabupaten/Kota. Kebijakan ini dilakukan untuk mengantisipasi dan mencegah penyebaran wabah virus COVID-19. Penelitian ini bertujuan untuk melihat kebijakan yang telah diterapkan oleh Pemerintah Kota Bogor dan menguji secara empiris data pasien COVID-19 untuk mengetahui faktor-faktor yang dapat mempengaruhi kematian pasien COVID-19. Hasil penelitian menunjukkan bahwa hampir semua pasien COVID-19 mematuhi protokol kesehatan yang ditetapkan Pemerintah Kota Bogor, namun pasien COVID-19 yang berusia lanjut, laki-laki, dan memiliki penyakit penyerta memiliki risiko kematian yang tinggi.
The full text of this article is available as PDF. Version of record published in Vol. 13 No. 3 (2021).
Copyright (c) 2021 Author(s). This article is licensed under CC Attribution-NonCommercial-ShareAlike 4.0.